This webinar will feature Sidley’s Food, Drug and Medical Device Compliance & Enforcement team in conversation with leaders from our Private Equity team addressing recent developments related to securing the drug supply chain and how the current regulatory landscape and challenges overseas are influencing efforts to repatriate drug manufacturing. We will explore:
- how COVID-19 has motivated the current Administration and investors to take steps to secure the U.S. drug supply chain,
- incentives for investing in domestic drug manufacturing, and
- common enforcement risks of which investors in onshore drug manufacturing should be aware.
Speakers:
Ayo K. Badejo
Moderator
Partner, M&A
Seth H. Katz
Partner, Private Equity
Arif S. Noorani
Partner, Food, Drug and Medical Device Compliance and Enforcement
Raj D. Pai
Partner, Food, Drug and Medical Device Compliance and Enforcement
Joyce J. Shin
Associate, Food, Drug and Medical Device Compliance and Enforcement
ABOUT THE SERIES
This is the second webinar in a series designed to discuss topics relevant to private equity investors in life sciences and healthcare. The first session covered the boom in telehealth and the key regulatory challenges to operating effectively in the telemedicine space. To watch the recording of that webinar, please click here. The next session will cover accelerated approval pathways. More information will be shared at a later date.
